SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Summit Therapeutics Starts Phase III HARMONi-10 Study of Ivonescimab

Summit initiated HARMONi-10, a global Phase III trial comparing ivonescimab with AstraZeneca's durva…

AZNSMMT

Related stories